Kirmani Jawad F, Alkawi Ammar, Ahmed Shafiuddin, Janjua Nazli, Khatri Ismail, Divani Afshin A, Qureshi Adnan I
Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Neurol Res. 2005;27 Suppl 1:S103-7. doi: 10.1179/016164105X35521.
Aneurysmal subarachnoid hemorrhage (aSAH) is a common and devastating form of stroke. A large number of patients with aSAH develop angiographic or clinical vasospasm responsible for high morbidity and mortality. Rapid advances in the field of interventional neurology and the development of minimally invasive techniques have resulted in expansion of potential therapeutic applications. Treatment of aSAH has benefited from this rapid advance in the field of endovascular therapies. In the first section of the review, we discuss the therapeutic options and techniques for embolizations of intracranial aneurysms. In the second section, we discuss evolving endovascular treatment methods employed to intervene in delayed complications of cerebral vasospasm in patients with aSAH.
动脉瘤性蛛网膜下腔出血(aSAH)是一种常见且具有破坏性的中风形式。大量aSAH患者会出现血管造影或临床血管痉挛,这是导致高发病率和死亡率的原因。介入神经病学领域的快速发展以及微创技术的开发,使得潜在治疗应用得到了扩展。aSAH的治疗受益于血管内治疗领域的这一快速进展。在综述的第一部分,我们讨论颅内动脉瘤栓塞的治疗选择和技术。在第二部分,我们讨论用于干预aSAH患者脑血管痉挛延迟并发症的不断发展的血管内治疗方法。